Neogen Chemicals
NEOGEN · NSE · Chemicals · India
Financials at a glance
Source: Yahoo FinanceAnnual
Quarterly · last 5
Revenue (FY2026)
₹862 Cr
Net margin
3.3%
Revenue CAGR (3y)
+7.9%
Profit CAGR (3y)
-16.8%
Net profit (FY2026)
₹29 Cr
Ask MarketChacha about NEOGEN
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Aug 5, 2026
Neogen Chemicals fell on concerns around the proposed ₹600 crore QIP fundraising (approved by the board in late July and up for shareholder vote at the Aug 21 AGM), which raises dilution fears; no fresh catalyst appeared on Aug 5 and the stock moved with broader specialty chemicals sentiment.
Daily moves with the verified reason behind them. Education only — not investment advice.
On MarketChacha
Posts about NEOGENFinancials
Yearly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| FY2026 | ₹862 Cr | ₹29 Cr | 3.3% |
| FY2025 | ₹778 Cr | ₹35 Cr | 4.5% |
| FY2024 | ₹691 Cr | ₹36 Cr | 5.2% |
| FY2023 | ₹686 Cr | ₹50 Cr | 7.3% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| Q1 FY27 | ₹250 Cr | ₹17 Cr | 6.29 | 6.8% |
| Q4 FY26 | ₹247 Cr | ₹11 Cr | — | 4.6% |
| Q3 FY26 | ₹220 Cr | ₹4 Cr | — | 1.7% |
| Q2 FY26 | ₹209 Cr | ₹3 Cr | — | 1.6% |
| Q1 FY26 | ₹187 Cr | ₹10 Cr | — | 5.5% |
Figures as reported, in ₹ (crore). Source: Yahoo Finance.
Filings & announcements
2026
Outcome Of The Meeting Of The Fund-Raising Committee Held On September 16, 2026
Outcome of Fund raising Committee meeting approving allotment of equity shares on QIP basis.
BSE9/17/2026Outcome of fund raising committee approving allotment of equity shares on QIP basis.
BSE9/17/2026Qualified Institutional Placement
Outcome of Fund raising committee approving allotment of equity shares on QIP basis
BSE9/17/2026Outcome Of Fund Raising Committee
Outcome of Fund raising committee held today approving closure of issue, issue price, placement document, and confirmation of allocation note
BSE9/16/2026Qualified Institutional Placement
Outcome of Fund Raising Committee held today approving closure of issue, issue price, placement document and confirmation of allocation note.
BSE9/16/2026Outcome Of Fund Raising Committee Meeting Held Today
Approval of Issue opening date and Floor price and PPD.
BSE9/10/2026Qualified Institutional Placement
Outcome of Fund raising committee meeting held today for opening of QIP issue.
BSE9/10/2026Show Cause cum Demand Notice received from Office of the Commissioner CGST.
BSE9/6/2026Approval for execution of Business Transfer Agreement between NIL and NML for sale/ transfer of undertaking/ assets as mentioned in detail in BTA by NIL to NML.
BSE8/31/2026Disclosure pursuant to regulation 7(2) of SEBI PIT Regulations.
BSE8/29/2026Submission Of Consolidated Voting Results And Scrutinizer''''s Report Of The 37Th AGM.
Submission of Consolidated Voting Results and Scrutinizer''s Report of the 37th AGM.
BSE8/22/2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Consolidated Voting Results and Scrutinizer''s Report of the 37th AGM.
BSE8/22/2026materialShareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 37th AGM.
BSE8/21/2026materialDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
BSE8/20/2026Earnings Call Transcript - Q1FY27
BSE8/1/2026Business Responsibility and Sustainability Reporting (BRSR)
BRSR and BRSR Assurance Report FY 2025-26.
BSE7/30/2026Notice Of 37Th AGM And Integrated Annual Report For FY 2025-26
Notice of 37th AGM and Integrated Annual Report for FY 2025-26.
BSE7/30/2026materialIntegrated Report for F.Y. 2025-26
BSE7/30/2026Outcome Of Analysts/ Investors Conference Call - Call Recording.
Outcome of Analysts/ Investors Conference Call - Call Recording.
BSE7/27/2026Earnings presentation on unaudited results for Q1FY2027.
BSE7/26/2026Press Release on unaudited results for Q1FY27.
BSE7/26/2026Revised Statement of Deviation/ Variation .
BSE7/24/2026Revised Statement Of Deviation/Variation
Revised Statement of Deviation/ Variation
BSE7/24/2026Monitoring Agency report and Statement of Deviation/ variation.
BSE7/24/2026Statement Of Deviation/ Variation And Monitoring Agency Report
Statement of Deviation & Variation and Monitoring Agency report
BSE7/24/2026
In the news
- Up 64% in 6 months already; should you still buy Neogen Chemicals? Antique sees 23% upside potential - Check targetLivemint · 10/20/2026
- Neogen Chemicals Share Price News: Valuation and Peer ViewUnivest · 10/15/2026
- Neogen Chemicals (NEOGEN.NS) Slips 5.61% to ₹2537.2 as Specialty Chemicals Stock Tests Key Support Zone - McClellan Summationhttps://www.siam.in/ · 10/15/2026
- Neogen Chemicals - Dynamatic Technologies among 7 stocks hitting 52-week highs; rally up to 32% in a monthThe Economic Times · 10/14/2026
- Neogen Chemicals Share Price Rally: Why It Jumped 15% in 3 DaysUnivest · 10/14/2026
- Neogen Chemicals share price jumps nearly 15% in 3 sessions | What's driving the rally, is more upside ahead?Livemint · 10/14/2026
- Neogen Chemicals 52 Week High Streak: Price and FundamentalsUnivest · 10/13/2026
- PVR Inox, Sky Gold, Neogen, West Coast Paper, PTC Ind, KMEW hit 52-wk highsBusiness Standard · 10/12/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.